Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: Evidence from a nationwide survey

Journal of Epidemiology and Community Health

Volumn 61, Issue 7, 2007, Pages 578-584

  Davaalkham, Dambadarjaa ^a   Ojima, Toshiyuki ^a   Wiersma, Steven ^b   Lkhagvasuren, Tserenkhuu ^c   Nymadawa, Pagvajav ^d   Uehara, Ritei ^a   Watanabe, Makoto ^a   Oki, Izumi ^a   Nakamura, Yosikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Health Sciences University   (Mongolia)

^d National Center for Communicable Diseases   (Mongolia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

DISEASE PREVALENCE; HEALTH SURVEY; HEPATITIS; IMMUNIZATION; INFECTIOUS DISEASE; PREDICTION; RURAL AREA; RURAL-URBAN COMPARISON; VACCINATION; VACCINE; WINTER;

CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; MALE; MONGOLIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORMAL HUMAN; OUTCOME ASSESSMENT; PREDICTION; PRIMARY PREVENTION; PROBABILITY; REVIEW; RURAL AREA; SCHOOL CHILD; SEASONAL VARIATION; SEROEPIDEMIOLOGY; URBAN RURAL DIFFERENCE; VACCINATION; WINTER;

CHILD; CROSS-SECTIONAL STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; JAPAN; MALE; MONGOLIA; RURAL HEALTH; SEASONS; TREATMENT OUTCOME;

ASIA; EURASIA; FAR EAST; MONGOLIA;

HEPATITIS B VIRUS;

EID: 34347266549     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2006.051375     Document Type: Review

References (32)

1. Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 2006;78:169-77.
2. World Health Organization. WHO vaccine-preventable diseases: monitoring system, 2004 global summary. Geneva: WHO, 2004.
3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107.
4. Cheriyan E. Monitoring the vaccine cold chain. Arch Dis Child 1993;69:600-1.
5. Nelson CM, Wibisono H, Purwanto H, et al. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. Bull World Health Organ 2004;82:99-105.
6. Galazka A, Milstein J, Zaffran M. Thermostability of vaccine, WHO document WHO/GPV/98.07. Geneva: World Health Organization, 1998.
7. Diminsky D, Moav N, Gorecki M, et al. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 1999;18:3-17.
8. Haworth EA, Booy R, Stirzaker L, et al. Is the cold chain for vaccines maintained in general practice? BMJ 1993;307:242-4.
9. Grasso M, Ripabelli G, Sammarco ML, et al. Vaccine storage in the community: a study in central Italy. Bull World Health Organ 1999;77:352-5.
10. Jeremijenko A, Kelly H, Sibthorpe B, et al. Improving vaccine storage in general practice refrigerators. BMJ 1996;312:1651-2.
11. Guthridge SL, Miller NC. Cold chain in a hot climate. Aust N Z J Public Health 1996;20:657-60.
12. Lugosi L, Battersby A. Transport and storage of vaccines in Hungary: the first cold chain monitor study in Europe. Bull World Health Organ 1990;68:431-9.
13. Hanjeet K, Lye MS, Sinniah M, et al. Evaluation of cold chain monitoring in Kelantan, Malaysia. Bull World Health Organ 1996;74:391-7.
14. Bishai DM, Bhatt S, Miller LT, et al. Vaccine storage practices in pediatric offices. Pediatrics 1992;89:193-6.
15. Edstam JS, Nyamkhuu D, Orgil T, et al. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev Med 2004;39:384-8.
16. Ministry of Health, Government of Mongolia. Health Sector Review-Mongolia. Ulaanbaatar: Ministry of Health, Government of Mongolia, 1999.
17. Goldstein ST, Zhou F, Hadler SC, et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005;34:1329-39.
18. Fujioka S, Shimomura H, Ishii Y, et al. Prevalence of hepatitis B and C virus markers in outpatients of Mongolian general hospitals. Kansenshogaku Zasshi 1998;72:5-11.
19. Takahashi M, Nishizawa T, Gotanda Y, et al. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 2004;11:392-8.
20. Davaalkham D, Ojima T, Nymadawa P, et al. Seroepidemiology of Hepatitis B virus infection in Mongolian children: a nationwide survey. Pediatr Int. In press.
21. Davaalkham D, Ojima T, Nymadawa P, et al. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: findings from a nationwide survey. J Med Virol 2006;78:466-72.
22. Hsu HY, Chang MH, Liaw SH, et al. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999;30:1312-17.
23. Davaalkham D, Ojima T, Uehara R, et al. Analysis of hepatitis B surface antigen mutations in Mongolia: molecular epidemiology and implications for mass vaccination. Arch Virol 2007;152:575-84.
24. Davaalkham D, Ojima T, Uehara R, et al. Impact of the universal hepatitis B immunization program in Mongolia: achievements and challenges. J Epidemiol. In press.
25. Lok AS. Chronic hepatitis B. N Engl J Med 2002;346:1682-3.
26. Asian development bank. Mongolia National Immunization Program financing assessment: Asian vaccination initiative financing assessment. http://www.adb.org/Publications/year.asp (accessed 20 Feb 2007).
27. Bell KN, Hogue CJ, Manning C, et al. Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics 2001;107:E100.
28. Thakker Y, Woods S. Storage of vaccines in the community: weak link in the cold chain? BMJ 1992;304:756-8.
29. Otto BF, Suarnawa IM, Stewart T, et al. At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain. Vaccine 1999;18:498-502.
30. Hipgrave DB, Tran TN, Huong VM, et al. Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam. Am J Trop Med Hyg 2006;74:255-60.
31. Hipgrave DB, Maynard JE, Biggs BA. Improving birth dose coverage of hepatitis B vaccine. Bull World Health Organ 2006;84:65-71.
32. National Center for Health Development, Ministry of Health of Mongolia. Annual Health Report-2004, Ulaanbaatar, 2004.http://www.moh.mn/ (accessed 20 Feb 2007).